To determine the effectiveness of routine culture based screening and risk based management in the prevention of early onset group B streptococcus disease (EOGBSD) and group B streptococcus (GBS) morbidity and mortality in the neonate as well as compare rates of intrapartum antibiotic prophylaxis (IAP) in both groups.
greater, as preterm infants are immunologically more prone to sepsis.
Prophylaxis
The two main methods employed in the prevention of EOGBSD are culture based screening and risk-based management. In both methods, EOGBSD prophylaxis focuses on interrupting the spread of the micro-organism from mother to neonate by administering prophylactic intravenous antibiotics to the mother in the intrapartum. 15, 16, 17 Maternal antibiotic therapy, however, may affect the community negatively because of the propensity for maternal allergic reactions, increase in drug resistant organisms, the exposure of neonates to antibiotics and the medicalization of birth required in the antibiotic therapy treatment process. 2, 18, 12 Other treatment options such as antenatal antibiotic therapy for GBS carriers or management of neonates after birth are not in use as they have been found ineffective 3 compared with IAP.
Screening
While future treatment options such as GBS vaccination and rapid bedside testing for maternal GBS colonisation are being explored as more effective EOGBSD strategies of prevention, the current mainstay of management is based on two main screening methods. These aim to identify women suitable for IAP; however neither has been evaluated in randomized controlled trials. The screening methods are:
1. Identifying women as at risk of GBS colonisation in labour through the clinical signs (risk factors) of: preterm labour at less than 37 weeks gestation, prolonged rupture of membranes, maternal pyrexia during labour equal to or more than 38 degrees Celsius, previous EOGBSD affected infant, and bacteriuria in the index pregnancy. These women are offered IAP. 15 This strategy is referred to in this review as risk based management or protocol.
2. Culturing a swab from the vagina and rectum of all women at 35-37 weeks gestation and offering IAP to those women whose swabs culture positive for GBS. [13] [14] [15] In a perfect application of this protocol, women who screen negative receive IAP for the development of any of the above mentioned risk factors. Women with an unknown GBS status in labour are treated as per risk based protocol. 14, 15 This strategy is referred to in this review as routine culture based screening or protocol. culture based protocol was found to be more efficacious as a) it prevented disease in infants of women colonised with GBS who were presented without GBS risk factors, and b) the adherence to IAP protocol by maternity care provider was higher with culture based screening. 19, 20 Accordingly, the CDC now endorses routine culture based screening over the risk based protocol. 14 United Kingdom guidelines do not recommend culture based screening on the basis that, at this point, it is still unclear as to whether this strategy does more good than harm. 3, 21 Globally, countries are divided as to EOGBSD prevention management and are influenced by the policy and guidelines in place in the USA and the UK. The evaluation of the screening strategies is based on observational studies. 22, 23 Whilst the incidence of EOGBSD in the UK is approximately 0.5 per 1000 live births in the absence of routine culture based screening, observational studies from the USA in 1996 suggest that the introduction of a national screening program for antenatal GBS carriage resulted in a substantial fall in the incidence of EOGBSD. One systematic review with meta-analysis has been published on this topic. 27 The inclusion criteria of this review are unclear and accordingly it is feasible to suggest that relevant studies may have been excluded with less relevant studies included. This second systematic review looks to offer a clearer picture of the evidence. It will aim to do this via tighter inclusion and exclusion definition, including studies of observational and experimental design as well as providing an updated overview of the evidence and the original review including studies published prior to January 2010.
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Inclusion criteria

Types of participants
This review will consider studies that include pregnant women (any gestation, parity, age) who were exposed to either routine culture based screening for GBS in pregnancy or risk based management for the prevention of EOGBSD in the neonate (seven days of age or less).
Types of interventions
This review will consider studies that compare routine culture based screening with risk based management for the prevention of early onset group B streptococcus disease in the neonate. This review will consider studies that compare these interventions as reported and defined by the authors.
Types of outcomes
This review will consider studies that include the following outcome measures:
1. Incidence of EOGBSD in all infants and term and preterm infants as separate groups. 3. Incidence of EOGBSD related morbidity and mortality in the infant under the culture based and risk based approach.
Incidence of intrapartum, intravenous antibiotic administration.
EOGBSD is defined as neonatal sepsis caused by Group B streptococcus isolated from an otherwise sterile site such as blood, urine, cerebrospinal fluid or tissue culture (postnatal age ≤ seven days).
Preterm is defined as < 37 weeks gestation.
GBS related mortality is any neonatal death attributable to EOGBSD acquired in a neonate.
Intrapartum intravenous antibiotic administration includes any intravenous antibiotic administration for EOGBSD prevention in the intrapartum period regardless of dosage, duration or type of antibiotic.
Types of studies
This review will include all randomized controlled trials, quasi-experimental, prospective and retrospective cohort studies that compare outcomes for women receiving routine culture based screening and risk based management for the prevention of EOGBSD in the neonate. Descriptive studies that do not include a comparator will be excluded.
Search strategy
The search strategy aims to find both published and unpublished studies. A three step search strategy will be utilised in this review. An initial limited search of MEDLINE AND CINAHL will be undertaken followed by an analysis of the text words contained in the title and abstract, and of the index terms used to describe an article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles will be searched for additional studies. Authors will be contacted in the case of missing data or to clarify unclear data. 
Studies published in English after
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using the standardized critical appraisal instrument, the Joanna Briggs
Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I).
Any disagreements that arise between the reviewers will be resolved through discussion or with a third reviewer.
Data collection
Data will be extracted from papers included in the review using the standardized data extraction tool from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives.
Data synthesis
Quantitative papers will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI.
Double data entry will be used for all results. Effect sizes, expressed as odds ratio (for categorical data) and weighted mean differences (for continuous data), and their 95% confidence intervals will be Page 67 calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi square and also explored using sensitivity analysis. Subgroup analysis based on population and intervention differences, study quality and different study designs included in this review will be considered, where appropriate. Where statistical pooling is not possible, the findings will be presented in narrative form including tables and figures to aid in data presentation where appropriate.
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